Skip to main content
NVDA+0.68%AAPL-0.39%MSFT-0.84%GOOGL-1.06%AMZN+0.37%TSM+1.40%SPCX-0.40%META-0.42%AVGO+2.33%TSLA+1.00%LLY+0.45%BRK-B+1.17%MU+2.31%SKHY+4.09%WMT+0.33%JPM+0.74%AMD+2.80%XOM+0.73%V-0.92%JNJ+0.94%ASMLa+1.27%MA-1.62%ABBV+0.40%INTC+4.04%CVX-0.51%1398.HK+2.15%0700.HK-0.31%COST+0.18%CSCO+3.51%KO-0.01%ORCL-0.08%PG-0.68%UNH-1.77%1816.HK+1.32%BAC-0.08%3988.HK+0.66%HD-0.14%CAT+0.75%0857.HK-0.98%PM+1.20%0939.HK+0.81%AP2d+1.13%AMAT+2.74%1288.HK+0.60%GE+0.98%LRCX+3.22%DELL+2.37%0005.HK-5.56%HSBA.L-6.75%NVS+1.78%NZDMXN+0.60%NZDJPY+0.57%USDJPY+0.57%EURNZD-0.52%AUDJPY+0.51%EURUSD-0.51%AUDDKK+0.46%NZDCHF+0.46%CADJPY+0.46%USDCHF+0.45%EURAUD-0.44%GBPTRY+0.41%AUDCHF+0.41%GBPUSD-0.39%GBPNZD-0.38%EURCAD-0.37%NZDSGD+0.36%CADCHF+0.33%GBPAUD-0.32%EURSEK-0.32%GBPHKD+0.32%USDPLN+0.31%EURCNH-0.29%GBPMXN-0.28%GBPCAD-0.27%EURHKD-0.27%USDMXN+0.27%USDDKK+0.26%AUDNOK+0.24%EURSGD-0.23%AUDSGD+0.23%EURNOK-0.22%CHFSEK-0.19%USDTRY+0.18%GBPJPY+0.18%USDILS+0.16%EURZAR-0.15%PLNJPY-0.14%SGDJPY+0.14%USDCAD+0.13%CHFJPY+0.13%NZDCAD+0.12%GBPSGD-0.12%NOKJPY+0.12%EURGBP-0.12%USDZAR+0.11%CHFSGD-0.09%CHFNOK-0.08%EURJPY+0.07%AUDNZD-0.07%EURCHF-0.07%USDTHB-0.07%USDSEK-0.07%AUDUSD-0.06%AUDCAD+0.06%GBPCHF+0.06%EURPLN+0.05%GBPZAR-0.05%USDNOK+0.05%USDCOP-0.04%USDHKD+0.04%USDSGD+0.03%USDCNH-0.02%EURDKK0.00%NZDUSD0.00%EURCZK0.00%COFFEE-1.78%XPTUSD-1.44%GAGUSD-1.25%XAGUSD-1.24%HG1+1.18%SUGAR+0.71%XNGUSD+0.66%S1+0.55%UKOIL-0.46%USOIL-0.28%W1+0.18%C1-0.16%BTCUSD-0.20%ETHUSD+23.96%USDTUSD0.00%XRPUSD+14.74%SOLUSD+17.47%TRXUSDT-0.15%ZECUSDT+1.59%DOGEUSD+20.65%XMRUSDT-0.52%LINKUSD+25.58%BCHUSDT-0.13%XLMUSD-0.78%UNIUSD-1.52%LTCUSD+17.89%SUIUSD-0.64%HBARUSDT-2.00%TONUSD+41.71%TAOUSDT-1.17%AAVEUSD-3.17%DOTUSDT-2.38%ICPUSDT-2.13%ONDOUSDT-1.80%WLDUSDT-0.78%ARBUSDT-0.95%JUPUSDT-1.50%INJUSDT-2.85%ATOMUSDT-1.80%STXUSDT-1.73%TIAUSDT-4.17%PYTHUSDT-3.40%FETUSDT-0.25%SEIUSDT-1.38%IMXUSDT-1.38%GRTUSDT-1.98%OPUSDT-1.09%IOTAUSDT+0.32%WIFUSDT-1.16%POLUSDT-1.83%AXSUSDT-0.96%EOSUSDT+0.58%FARTCOINUSDT+0.44%DYDXUSDT-0.51%GALAUSDT-1.91%ORDIUSDT-0.38%RONINUSDT+0.02%NOTUSDT-0.80%NVDA+0.68%AAPL-0.39%MSFT-0.84%GOOGL-1.06%AMZN+0.37%TSM+1.40%SPCX-0.40%META-0.42%AVGO+2.33%TSLA+1.00%LLY+0.45%BRK-B+1.17%MU+2.31%SKHY+4.09%WMT+0.33%JPM+0.74%AMD+2.80%XOM+0.73%V-0.92%JNJ+0.94%ASMLa+1.27%MA-1.62%ABBV+0.40%INTC+4.04%CVX-0.51%1398.HK+2.15%0700.HK-0.31%COST+0.18%CSCO+3.51%KO-0.01%ORCL-0.08%PG-0.68%UNH-1.77%1816.HK+1.32%BAC-0.08%3988.HK+0.66%HD-0.14%CAT+0.75%0857.HK-0.98%PM+1.20%0939.HK+0.81%AP2d+1.13%AMAT+2.74%1288.HK+0.60%GE+0.98%LRCX+3.22%DELL+2.37%0005.HK-5.56%HSBA.L-6.75%NVS+1.78%NZDMXN+0.60%NZDJPY+0.57%USDJPY+0.57%EURNZD-0.52%AUDJPY+0.51%EURUSD-0.51%AUDDKK+0.46%NZDCHF+0.46%CADJPY+0.46%USDCHF+0.45%EURAUD-0.44%GBPTRY+0.41%AUDCHF+0.41%GBPUSD-0.39%GBPNZD-0.38%EURCAD-0.37%NZDSGD+0.36%CADCHF+0.33%GBPAUD-0.32%EURSEK-0.32%GBPHKD+0.32%USDPLN+0.31%EURCNH-0.29%GBPMXN-0.28%GBPCAD-0.27%EURHKD-0.27%USDMXN+0.27%USDDKK+0.26%AUDNOK+0.24%EURSGD-0.23%AUDSGD+0.23%EURNOK-0.22%CHFSEK-0.19%USDTRY+0.18%GBPJPY+0.18%USDILS+0.16%EURZAR-0.15%PLNJPY-0.14%SGDJPY+0.14%USDCAD+0.13%CHFJPY+0.13%NZDCAD+0.12%GBPSGD-0.12%NOKJPY+0.12%EURGBP-0.12%USDZAR+0.11%CHFSGD-0.09%CHFNOK-0.08%EURJPY+0.07%AUDNZD-0.07%EURCHF-0.07%USDTHB-0.07%USDSEK-0.07%AUDUSD-0.06%AUDCAD+0.06%GBPCHF+0.06%EURPLN+0.05%GBPZAR-0.05%USDNOK+0.05%USDCOP-0.04%USDHKD+0.04%USDSGD+0.03%USDCNH-0.02%EURDKK0.00%NZDUSD0.00%EURCZK0.00%COFFEE-1.78%XPTUSD-1.44%GAGUSD-1.25%XAGUSD-1.24%HG1+1.18%SUGAR+0.71%XNGUSD+0.66%S1+0.55%UKOIL-0.46%USOIL-0.28%W1+0.18%C1-0.16%BTCUSD-0.20%ETHUSD+23.96%USDTUSD0.00%XRPUSD+14.74%SOLUSD+17.47%TRXUSDT-0.15%ZECUSDT+1.59%DOGEUSD+20.65%XMRUSDT-0.52%LINKUSD+25.58%BCHUSDT-0.13%XLMUSD-0.78%UNIUSD-1.52%LTCUSD+17.89%SUIUSD-0.64%HBARUSDT-2.00%TONUSD+41.71%TAOUSDT-1.17%AAVEUSD-3.17%DOTUSDT-2.38%ICPUSDT-2.13%ONDOUSDT-1.80%WLDUSDT-0.78%ARBUSDT-0.95%JUPUSDT-1.50%INJUSDT-2.85%ATOMUSDT-1.80%STXUSDT-1.73%TIAUSDT-4.17%PYTHUSDT-3.40%FETUSDT-0.25%SEIUSDT-1.38%IMXUSDT-1.38%GRTUSDT-1.98%OPUSDT-1.09%IOTAUSDT+0.32%WIFUSDT-1.16%POLUSDT-1.83%AXSUSDT-0.96%EOSUSDT+0.58%FARTCOINUSDT+0.44%DYDXUSDT-0.51%GALAUSDT-1.91%ORDIUSDT-0.38%RONINUSDT+0.02%NOTUSDT-0.80%
IP

Ironwood Pharmaceuticals, Inc. (IRWD)

NASDAQ • Healthcare

$3.5
+$0.04 (+1.2%)
Market closed

Last close at October 26, 2026 at 20:00 UTC

Open$3.49
Day Range$3.45 - $3.54
Avg. Volume (3M)1.7M
Market Cap$578.3M
P/E Ratio4.4
52 Week Range
$1.47$5.78
Next EarningsIn 13 daysNov 9, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$113M100%
Gross Profitminus cost of goods$113M100%
Operating Incomeminus R&D and overhead$79.3M70%
Net Incomeminus taxes and the rest$51.2M45%

In plain terms: out of every $100 in revenue, Ironwood Pharmaceuticals, Inc. keeps $45 as net profit.

Fundamentals & Financials

Revenue (TTM)
$389.3M
Net Income (TTM)
$129.8M
EPS (TTM)
$0.8
ROA (TTM)
45.55%
Current Ratio
6.06

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-150.0%Q1 2026-$0.01
+242.9%Q2 2026$0.24
-3.1%Q3 2026$0.31
Next

Nov 9

in 13 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Next report — what to expect

Ironwood Pharmaceuticals, Inc. (IRWD) reports earnings on November 9, 2026. Wall Street expects EPS of $0.323 on revenue of $120.0 million. For trailing context, revenue grew +32.6% year over year last quarter. Ironwood has beaten EPS in 3 of its 8 most recent quarters.

View full earnings history

About Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals, Inc. develops and commercializes medicines for gastrointestinal conditions and related disorders, operating in the healthcare sector as a specialty drug maker listed on NASDAQ as IRWD. Its business centers on linaclotide and the brands LINZESS and CONSTELLA, and it generated $296.2 million of revenue in FY2025.

Name
Ironwood Pharmaceuticals, Inc.
CEO
Thomas A. McCourt
Website
www.ironwoodpharma.com
Industry
Healthcare
Year Founded
1998
Employees
100

Today's Snapshot

AI-generated

IRWD closed 1.2% higher at 3.50, while its sector was flat. Volume was about two-thirds of its usual level. IRWD reports earnings on 9 November.

Trading Volume

Below 10d avg (1.6M)

1M

vs S&P 500 Today

Moderate Outperformance

+0.47%

Updated: October 26, 2026 at 20:14 UTC

Technical Indicators

1 Buy1 Neutral6 Sell
IRWD is trading below most short- and medium-term averages while also sitting under its longer-term levels, which supports the current sell bias. Momentum measures are weak, with MACD and short-term momentum showing negative readings and RSI below neutral, while the ADX indicates only a modest trend, suggesting limited directional conviction. Volatility is moderate relative to price, and the pivot sits very near the market, offering a nearby reference. On the other hand, OBV shows positive accumulation, tempering the bearish picture. Technical takeaway: Sell bias remains in place amid weak momentum and limited trend strength.
All signals
  • EMA (5 indicators)$3.59 - $3.94
    Sell
  • RSI (14)39.19
    Neutral
  • Stochastic %K (14, 3, 3)17.42
    Buy
  • MACD Level (12, 26)-0.15
    Sell

Peers & Related Assets

SYRESpyre Therapeutics, Inc.
$92.91+2.9%
ARDXArdelyx, Inc.
$3-2.6%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.